Roche appeals, fights for new Accutane judge 
Published: March 11, 2013
Tags: Accutane, birth defects, DRI, drug litigation, Hoffmann-La Roche, inflammatory bowel disease, recusal
Continuing in its efforts to find a new judge for the thousands of Accutane cases pending in New Jersey state court, Hoffman-La Roche filed notice to appeal a decision by presiding Judge Carol E. Higbee not to recuse herself in the case.
N.J. judge refuses to recuse herself from Accutane cases
Published: March 4, 2013
Tags: Accutane, birth defects, DRI, drug litigation, Hoffmann-La Roche, inflammatory bowel disease, recusal, suicide
The state judge overseeing Accutane mass tort litigation in New Jersey has denied Hoffmann- La Roche’s motion asking that she recuse herself.
Hoffmann-La Roche asks for Accutane judge’s recusal
Published: December 28, 2012
Tags: Accutane, drug litigation, Hoffmann-La Roche, inflammatory bowel disease, mass tort litigation, recusal
Drug maker Hoffmann- La Roche has asked for the recusal of the New Jersey judge overseeing the Accutane mass tort litigation, asserting that Judge Carol E. Higbee is siding unfairly with plaintiffs who allege injuries from the acne drug.
Accutane warning ruled adequate
Published: August 2, 2012
Tags: Accutane, Hoffmann-La Roche, inflammatory bowel disease, product liability
Pharmaceutical company Hoffmann-La Roche adequately warned a user of the acne drug Accutane of the risk of developing inflammatory bowel disease, a U.S. District Court in Florida has ruled in granting summary judgment.
